Radiosynthesis and biological evaluation of an 18F-labeled derivative of the novel pyrazolopyrimidine sedative-hypnotic agent indiplon.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nuclear Medicine and Biology

• Publication date

  2007-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NUCMEDBIO.2007.03.011PMID 17591556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.

  2006cited by this paper
• Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls.

  2006cited by this paper
• Indiplon Is a High-Affinity Positive Allosteric Modulator with Selectivity for α1 Subunit-Containing GABAA Receptors

  2006cited by this paper
• Developmental changes in the expression of GABAA receptor alpha 1 and gamma 2 subunits in human temporal lobe, hippocampus and basal ganglia: an implication for consideration on age-related epilepsy.

  2006cited by this paper
• Enhancing GABAA Receptor α1 Subunit Levels in Hippocampal Dentate Gyrus Inhibits Epilepsy Development in an Animal Model of Temporal Lobe Epilepsy

  2006cited by this paper
• Increased GABAA‐Receptor α1‐Subunit Expression in Hippocampal Dentate Gyrus after Early‐life Status Epilepticus

  2006cited by this paper
• Learning deficits induced by sleep deprivation and recovery are not associated with altered [(3)H]muscimol and [(3)H]flunitrazepam binding.

  2005cited by this paper
• Ion channels and epilepsy.

  2005cited by this paper
• Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.

  2005cited by this paper
• Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography.

  2005cited by this paper
• GABA(A) receptor channel pharmacology.

  2005cited by this paper
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors

  2005cited by this paper
• Consequences of the Evolution of the GABAA Receptor Gene Family

  2005cited by this paper
• Brain Imaging in Idiopathic Generalized Epilepsies

  2005cited by this paper
• GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study

  2005cited by this paper
• Indiplon: the development of a new hypnotic

  2005cited by this paper
• Alcohol, GABA receptors, and neurodevelopmental disorders.

  2005cited by this paper
• Biological properties of 2'-[18F]fluoroflumazenil for central benzodiazepine receptor imaging.

  2005cited by this paper
• Sleep, epilepsy and thalamic reticular inhibitory neurons.

  2005cited by this paper
• Changes of [3H]Muscimol, [3H]Flunitrazepam and [3H]MK-801 Binding in Rat Brain by Prolonged Ventricular Infusion of 7-Nitroindazole

  2004cited by this paper
• GABAA receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil

  2004cited by this paper
• In Vivo Pharmacological Characterization of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic

  2004cited by this paper
• Development of radioligands for in vivo imaging of GABA(A)-benzodiazepine receptors.

  2004cited by this paper
• Biological evaluation of 2'-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET.

  2004cited by this paper
• Development of effective therapeutics targeting the GABAA receptor: naturally occurring alternatives.

  2004cited by this paper
• The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats.

  2004cited by this paper
• Decrease in Cortical Benzodiazepine Receptors in Symptomatic Patients With Leukoaraiosis: A Positron Emission Tomography Study

  2004cited by this paper
• [PET in neuroscience: dopaminergic, GABA/benzodiazepine, and opiate system].

  2004cited by this paper
• Characterization of the Interaction of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic, with the GABAA Receptor

  2004cited by this paper
• Substitution‐reduction: an alternative process for the [18F]N‐(2‐fluoroethylation) of anilines

  2004cited by this paper
• Measurement of brain concentration of FK960 for development of a novel antidementia drug: a PET study in conscious rhesus monkeys.

  2003cited by this paper
• Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies?

  2003cited by this paper
• Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptors.

  2003cited by this paper
• Radiosynthesis of 3-(2'-[18F]fluoro)-flumazenil ([18F]FFMZ)

  2003cited by this paper
• Novel one-pot one-step synthesis of 2'-[(18)F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging.

  2003cited by this paper
• The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem.

  2002cited by this paper
• Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate.

  2001cited by this paper
• [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors

  2001cited by this paper
• Postnatal maturation of human GABAA receptors measured with positron emission tomography

  2001cited by this paper
• Yohimbine increases the binding potential for [11C]flumazenil in the monkey brain

  2001cited by this paper
• GABA(A)-receptor subtypes: a new pharmacology.

  2001cited by this paper
• Benzodiazepine receptor binding in Huntington's disease: [11C]Flumazenil uptake measured using positron emission tomography

  2000cited by this paper
• Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study

  1999cited by this paper
• Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

  1998cited by this paper
• Positron Emission Tomography Receptor Studies

  1997cited by this paper
• Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.

  1995cited by this paper
• PET imaging of neuroreceptors in schizophrenia.

  1995cited by this paper
• Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical, EEG and neuroimaging features in 100 adult patients.

  1995cited by this paper
• Positron emission tomography measures of benzodiazepine receptors in Huntington's disease

  1993cited by this paper
• Discrepancies in Perfusion Defect Estimates Between Tc-99m Mibi Spect and N-13 Ammonia Pet Are Not Explained By Differences in Tracer Behavior

  1993cited by this paper
• A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z.

  1993cited by this paper
• Binding of 5-(2'-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography.

  1992cited by this paper
• The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development

  1992cited by this paper
• The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon

  1992cited by this paper
• GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.

  1990cited by this paper
• Evaluation of radiolabeled acetate and fluoroacetate as potential tracers of cerebral oxidative metabolism

  1990cited by this paper
• Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists.

  1988cited by this paper
• In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci.

  1988cited by this paper
• Status epilepticus induced by pentylenetetrazole modulates in vivo [11C]Ro 15-1788 binding to benzodiazepine receptors. Effects of ligands acting at the supramolecular receptor complex.

  1988cited by this paper
• Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography.

  1984cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• USE AND ABUSE OF ELECTROENCEPHALOGRAPHY.

  1964cited by this paper

• Rational approaches for the design of various GABA modulators and their clinical progression

  2020cites this paper
• Development of 18F-labeled radiotracers for neuroreceptor imaging with positron emission tomography

  2014cites this paper
• Development of 18 F-labeled radiotracers for neuroreceptor imaging with positron emission tomography

  2014cites this paper
• Use of 3-[18F]fluoropropanesulfonyl chloride as a prosthetic agent for the radiolabelling of amines: Investigation of precursor molecules, labelling conditions and enzymatic stability of the corresponding sulfonamides

  2013cites this paper
• PET radioligands targeting the brain GABAA /benzodiazepine receptor complex.

  2013cites this paper
• 3-(4-Bromophenyl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazole-1-carbothioamide

  2011cites this paper
• GABAA Receptor Specific Pyrazolopyrimidines as Potential Imaging Agents: In Vivo Characteristics of a New 18F-labelled Indiplon Derivative

  2009cites this paper
• Ethyl {4‐[2‐(saccharin‐2‐yl)acetylsulfamoyl]phenylazo}cyanoacetate in the synthesis of polyfunctionally heteroaromatic derivatives

  2009cites this paper
• Regioselective synthesis and bioactivity of new 5-amino-6-arylamino-pyrazolo[3,4-d]-pyrimidin-4(5H)-one derivatives

  2009cites this paper
• GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.

  2008cites this paper
• Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies.

  2008cites this paper